Vaxcyte, Inc.
$63.62
-1.65 (-2.53%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- +5.4%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -13.8%
Own PCVX?
See how PCVX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.